There is much discussion around the need for transparency in the healthcare sector, with patient advocacy groups being a strong voice in this discussion. However, what about their own transparency?
“Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations….
The database, called “Pre$cription for Power,” shows that donations to patient advocacy groups tallied for 2015 — the most recent full year in which documents required by the Internal Revenue Service were available — dwarfed the total amount the companies spent on federal lobbying. The 14 companies that contributed $116 million to patient advocacy groups reported only about $63 million in lobbying activities that same year.
There is much discussion occurring in Canada and elsewhere around the issue of assisted dying. Not surprisingly, oft times, the conversation becomes a religious debate.
In a recent article found in the Globe and Mail, Jonathan Reggler, a general physician who makes daily patient visits to St. Joseph’s Hospital in Comox, B.C., took a stand against the hospital’s assisted-dying policy. While it is true that Catholic hospitals across the country are transferring patients who request assisted suicide to facilities where this can occur, the process can involve a great deal of emotional, mental and physical pain to the patient and his/her family. With such suffering being inflicted on the patient and the fact that the service requested is being carried out elsewhere, the question being asked is: Should faith-based hospitals should receive public funding? As Daphne Gilbert, a law professor at the University of Ottawa, states, “The Catholic hospitals have put themselves in a tricky position.” Click here to read the full article.